Doctor’s Life Simulator

[In order to further suppress Ming's Pharmaceutical Group, the person in charge of Pfizer's Huaguo District even found a muddy water agency in the United States and wrote an investigation report on Ming's Pharmaceutical Group to further short. Within half a month, the assets of Ming's Pharmaceutical Group were only one-tenth of their peak value. 】

[Although Ming Dong held a press conference, and at the same time, the executives of the joint venture repurchased US$50 million of the company's stock, it still failed to arouse the confidence of the outside world in Ming's Pharmaceutical Group. Due to investing in your company and investing in the medical school of the First Affiliated Hospital of Zijingang to build a building and purchase equipment, the cash flow was tight for a while. The research projects invested have not achieved breakthroughs. Ming's Pharmaceutical Group is in a desperate situation. 】

[Ming Dong and your new company's new anti-tumor drug is still in the first stage, so it can't provide much help. Fortunately, the modified ICR mouse inbred line project and your previous modified microskin combined with carbon fiber transplantation project are progressing smoothly. 】

[One month later, due to the short-selling report of the Muddy Water Agency and the encirclement and suppression of foreign capital, Ming's Pharmaceutical Group had to give up its struggle and was acquired by Pfizer Group at a low price. During the negotiation, you proposed to detach the new drug project that Mingshi Pharmaceutical Group invested heavily in and merge it into a new company with you and Ming Dong Kai. Pfizer Group has no interest in such semi-finished products and agreed. 】

[Ming's Pharmaceutical Group has now disappeared, and Ming Dong has also become increasingly depressed. However, your new company is developing well. Although it cannot reach the scale of the previous Mingshi Pharmaceutical Group, it will support the new drug research and development laboratory of Zijingang No. 1 Hospital in place of Mingshi Pharmaceutical Group. It's just that your newly opened pharmacy major was eventually stranded because of these things. Wen Yunqi was helpless about this. After all, compared with a world-class pharmaceutical giant like Pfizer, Ming's Pharmaceutical Group was too immature. 】

[You continue to learn the surgical procedures of the ventricular correction surgery series in Director Huang's Department of Cardiovascular Medicine. With your previous accumulation, although you have no outstanding achievements later, you are still an elite-level surgeon. 】

[One year later, you returned to the First City Hospital. Because of your excellent level in several fields, you have a lot of freedom in the City First Court. It's just, incomprehensible, that you put most of your experience into ventricular surgery. 】

[At the age of twenty-eight, you were promoted to chief physician. At the same time, you have made some progress in ventricular correction, your natural blessing is to activate your heart, and you have understood and mastered the improved-Taussig shunt. 】

[In the same year, you accidentally discovered that the new drug launched by Pfizer Group had serious side effects, and there was only a lack of reports before, but in the end, time will tell. The first person who discovered and sorted out this situation was a top expert in Zhejiang Province, Gao Jun, the vice president of Zhejiang Provincial Hospital of Traditional Chinese Medicine, and Professor Gao. 】

[Professor Gao spent more than a year conducting various experiments, and found that the animal experimental data before Pfizer's new drug was suspected of falsification. At the same time, relying on his own network, he collected enough case data across the country, and after leading the team to make statistics, he came to the conclusion that this new drug of Pfizer has serious side effects, causing severe depression, myocardial infarction, schizophrenia, angina pectoris and other symptoms. . Professor Gao directly sent an article to the top journal "The Lancet\